Mosunetuzumab monotherapy demonstrates encouraging activity and a manageable safety profile in patients with heavily pre-treated relapsed or refractory mantle cell lymphoma Meeting Abstract
| Authors: | Budde, E. L.; Matasar, M.; Sehn, L. H.; Assouline, S. E.; Kuruvilla, J.; Flinn, I. W.; Yoon, S. S.; Bosch, F.; Greenwald, D.; Gutierrez, N. C.; Tzachanis, D.; Marlton, P.; McGuirt, D.; Yin, S.; Wei, M. C.; Kwan, A.; Tracy, S.; Penuel, E.; Bartlett, N. L. |
| Abstract Title: | Mosunetuzumab monotherapy demonstrates encouraging activity and a manageable safety profile in patients with heavily pre-treated relapsed or refractory mantle cell lymphoma |
| Meeting Title: | 66th Annual Meeting of the American Society of Hematology (ASH) |
| Journal Title: | Blood |
| Volume: | 144 |
| Issue: | Suppl. 1 |
| Meeting Dates: | 2024 Dec 7-10 |
| Meeting Location: | San Deigo, CA |
| ISSN: | 0006-4971 |
| Publisher: | American Society of Hematology |
| Date Published: | 2024-11-05 |
| Start Page: | 1646 |
| End Page: | 1648 |
| Language: | English |
| ACCESSION: | WOS:001412765900001 |
| DOI: | 10.1182/blood-2024-197902 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract -- Hybrid event -- Source: Wos |
